PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
TPL vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

TPL vs. CPRX

Last updated May 18, 2025

Compare and contrast key facts about Texas Pacific Land Corporation (TPL) and Catalyst Pharmaceuticals, Inc. (CPRX).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TPL or CPRX.

Correlation

The correlation between TPL and CPRX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

TPL vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Texas Pacific Land Corporation (TPL) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

TPL:

2.52

CPRX:

1.19

Sortino Ratio

TPL:

2.92

CPRX:

1.95

Omega Ratio

TPL:

1.43

CPRX:

1.22

Calmar Ratio

TPL:

3.73

CPRX:

1.65

Martin Ratio

TPL:

8.27

CPRX:

6.46

Ulcer Index

TPL:

16.93%

CPRX:

7.40%

Daily Std Dev

TPL:

55.91%

CPRX:

41.35%

Max Drawdown

TPL:

-73.05%

CPRX:

-94.25%

Current Drawdown

TPL:

-17.13%

CPRX:

-5.32%

Fundamentals

Market Cap

TPL:

$32.88B

CPRX:

$2.97B

EPS

TPL:

$20.03

CPRX:

$1.57

PE Ratio

TPL:

71.42

CPRX:

15.52

PEG Ratio

TPL:

0.00

CPRX:

0.00

PS Ratio

TPL:

45.19

CPRX:

5.56

PB Ratio

TPL:

27.26

CPRX:

3.65

Total Revenue (TTM)

TPL:

$727.66M

CPRX:

$534.65M

Gross Profit (TTM)

TPL:

$653.55M

CPRX:

$441.72M

EBITDA (TTM)

TPL:

$586.43M

CPRX:

$250.28M

Returns By Period

In the year-to-date period, TPL achieves a 29.49% return, which is significantly higher than CPRX's 16.77% return. Over the past 10 years, TPL has outperformed CPRX with an annualized return of 41.29%, while CPRX has yielded a comparatively lower 19.87% annualized return.

TPL

YTD

29.49%

1M

10.16%

6M

5.42%

1Y

138.97%

5Y*

53.20%

10Y*

41.29%

CPRX

YTD

16.77%

1M

8.21%

6M

18.30%

1Y

47.79%

5Y*

40.03%

10Y*

19.87%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

TPL vs. CPRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
TPL
The Risk-Adjusted Performance Rank of TPL is 9696
Overall Rank
The Sharpe Ratio Rank of TPL is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of TPL is 9494
Sortino Ratio Rank
The Omega Ratio Rank of TPL is 9595
Omega Ratio Rank
The Calmar Ratio Rank of TPL is 9898
Calmar Ratio Rank
The Martin Ratio Rank of TPL is 9393
Martin Ratio Rank
CPRX
The Risk-Adjusted Performance Rank of CPRX is 8686
Overall Rank
The Sharpe Ratio Rank of CPRX is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8080
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TPL vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Texas Pacific Land Corporation (TPL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TPL Sharpe Ratio is 2.52, which is higher than the CPRX Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of TPL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Dividends

TPL vs. CPRX - Dividend Comparison

TPL's dividend yield for the trailing twelve months is around 1.09%, while CPRX has not paid dividends to shareholders.

TTM20242023202220212020201920182017201620152014
TPL
Texas Pacific Land Corporation		1.09%1.58%0.83%1.37%0.88%3.58%0.77%0.75%0.30%0.10%0.22%0.23%
CPRX
Catalyst Pharmaceuticals, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TPL vs. CPRX - Drawdown Comparison

The maximum TPL drawdown since its inception was -73.05%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for TPL and CPRX. For additional features, visit the drawdowns tool.

Loading data...

Volatility

TPL vs. CPRX - Volatility Comparison

Texas Pacific Land Corporation (TPL) has a higher volatility of 10.65% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 10.00%. This indicates that TPL's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

TPL vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Texas Pacific Land Corporation and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

50.00M100.00M150.00M200.00M20212022202320242025
195.98M
141.42M
(TPL) Total Revenue
(CPRX) Total Revenue
Values in USD except per share items

TPL vs. CPRX - Profitability Comparison

The chart below illustrates the profitability comparison between Texas Pacific Land Corporation and Catalyst Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
80.0%85.0%90.0%95.0%20212022202320242025
88.2%
87.3%
(TPL) Gross Margin
(CPRX) Gross Margin
TPL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported a gross profit of 172.92M and revenue of 195.98M. Therefore, the gross margin over that period was 88.2%.

CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.

TPL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported an operating income of 150.07M and revenue of 195.98M, resulting in an operating margin of 76.6%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.

TPL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported a net income of 120.65M and revenue of 195.98M, resulting in a net margin of 61.6%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.